Top News

RESEARCH

21 Jun 2025

Stem Cell Trial Offers Hope for Insulin-Free Diabetes

Vertex's zimislecel left most trial patients insulin-free after a year, but safety risks and scalability remain major hurdles

Gloved hand uses tweezers to edit a DNA strand against a blue background.

INNOVATION

28 Jun 2025

CRISPR’s Bold Bet: One Shot to Disrupt Cholesterol Care

Close-up of a Novo-branded white pill on a reflective dark surface.

INNOVATION

25 Jun 2025

From Needle to Pill: The New Face of Obesity Treatment

Latest News

INVESTMENT
12 Jan 2026
Lilly’s Ventyx Deal Points to a Future Beyond Injections
MARKET TRENDS
8 Jan 2026
Oral Weight Loss Pills Are Shaking Up Metabolic Care
PARTNERSHIPS
6 Jan 2026
Pfizer’s Metsera Deal Ignites a New Obesity Drug Arms Race
RESEARCH
19 Dec 2025
Liver-First Drugs Redefine the Next Phase of the MASH Race

FDA Pilot Voucher Signals Faster Reviews for Metabolic Drugs

Business discussion reflecting FDA pilot voucher accelerating metabolic drug reviews

REGULATORY

18 Dec 2025

A new FDA pilot voucher could shrink review timelines for select obesity and diabetes drugs, stirring optimism and debate across the sector

Eli Lilly corporate headquarters sign outside company office building

INVESTMENT

12 Jan 2026

Lilly’s Ventyx Deal Points to a Future Beyond Injections

Eli Lilly’s $1.2B Ventyx buy shows growing confidence in oral small-molecule drugs aimed at inflammation and long-term metabolic health

Oral weight loss pills with measuring tape illustrating shift in obesity treatment

MARKET TRENDS

8 Jan 2026

Oral Weight Loss Pills Are Shaking Up Metabolic Care

Oral obesity drugs are widening access, shifting pricing power, and forcing drugmakers and health platforms to rethink how metabolic care ...

Pfizer research facility following Metsera acquisition in obesity drug strategy

PARTNERSHIPS

6 Jan 2026

Pfizer’s Metsera Deal Ignites a New Obesity Drug Arms Race

Pfizer’s Metsera buy sharpens its obesity strategy and signals a fiercer, faster fight for metabolic drug leadership

RESEARCH

19 Dec 2025

Liver-First Drugs Redefine the Next Phase of the MASH Race

New 2025 data for Ionis ION224 highlight how liver-targeted drugs and GLP-1s may converge to reshape MASH care and deal-making

REGULATORY

18 Dec 2025

FDA Pilot Voucher Signals Faster Reviews for Metabolic Drugs

A new FDA pilot voucher could shrink review timelines for select obesity and diabetes drugs, stirring optimism and debate across the secto...

Colorful 3D rendering of mitochondria used in metabolic research

INNOVATION

17 Dec 2025

The Next Obesity Bet Lies Deep Inside Cells

As GLP-1 drugs dominate obesity care, a handful of biotechs are probing mitochondria, searching for new metabolic levers inside the cell

1 2 3...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.